{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T11:02:35Z","timestamp":1784545355073,"version":"3.55.0"},"reference-count":14,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T00:00:00Z","timestamp":1778112000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jcardioanesthesia.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cardiothoracic and Vascular Anesthesia"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1053\/j.jvca.2026.05.018","type":"journal-article","created":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T15:16:34Z","timestamp":1778339794000},"page":"2466-2473","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Evaluation of Activated Clotting Time Response to Unfractionated Heparin in Vascular Surgery: An Observational Study"],"prefix":"10.1053","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-6137-8295","authenticated-orcid":false,"given":"Roberta","family":"Garberi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuela","family":"Milan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Palermo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vittorio Maria","family":"Segramora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Casati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8235-9313","authenticated-orcid":false,"given":"Matteo","family":"Pozzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8698-2046","authenticated-orcid":false,"given":"Giuseppe","family":"Foti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8048-2721","authenticated-orcid":false,"given":"Marco","family":"Giani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.jvca.2026.05.018_bib0001","doi-asserted-by":"crossref","first-page":"488","DOI":"10.23736\/S0021-9509.23.12723-6","article-title":"Unfractionated heparin and the activated clotting time in non-cardiac arterial procedures","volume":"64","author":"Roosendaal","year":"2023","journal-title":"J Cardiovasc Surg"},{"key":"10.1053\/j.jvca.2026.05.018_bib0002","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.avsg.2022.01.029","article-title":"Weight based heparin dosage with activated clotting time monitoring leads to adequate and safe anticoagulation in non-cardiac arterial procedures","volume":"84","author":"Doganer","year":"2022","journal-title":"Ann Vasc Surg"},{"key":"10.1053\/j.jvca.2026.05.018_bib0003","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1001\/jama.1966.03100180108036","article-title":"Activated coagulation time of whole blood","volume":"196","author":"Hattersley","year":"1966","journal-title":"JAMA"},{"key":"10.1053\/j.jvca.2026.05.018_bib0004","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1053\/j.jvca.2017.04.047","article-title":"Pro: Activated clotting time should be monitored during heparinization for vascular surgery","volume":"32","author":"Goldhammer","year":"2018","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"10.1053\/j.jvca.2026.05.018_bib0005","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1177\/17085381241283519","article-title":"Systematic review of clinical guidelines and consensus statements concerning heparin and protamine dosing and monitoring of anticoagulation levels for non-cardiac arterial procedures","volume":"33","author":"Roosendaal","year":"2025","journal-title":"Vascular"},{"key":"10.1053\/j.jvca.2026.05.018_bib0006","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.jvs.2017.11.079","article-title":"Comparison between activated clotting time and anti-activated factor X activity for the monitoring of unfractionated heparin therapy in patients with aortic aneurysm undergoing an endovascular procedure","volume":"68","author":"Dieplinger","year":"2018","journal-title":"J Vasc Surg"},{"key":"10.1053\/j.jvca.2026.05.018_bib0007","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1093\/bja\/ael194","article-title":"Anticoagulation monitoring during vascular surgery: Accuracy of the Hemochron\u00ae low range activated clotting time (ACT-LR)","volume":"97","author":"Tremey","year":"2006","journal-title":"Br J Anaesth"},{"key":"10.1053\/j.jvca.2026.05.018_bib0008","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1177\/0300060517731952","article-title":"Comparison of activated clotting times measured using the Hemochron Jr. Signature and Medtronic ACT Plus during cardiopulmonary bypass with acute normovolemic haemodilution","volume":"46","author":"Lee","year":"2018","journal-title":"J Int Med Res"},{"key":"10.1053\/j.jvca.2026.05.018_bib0009","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1160\/TH08-08-0528","article-title":"Comparison of activated clotting times obtained using Hemochron and Medtronic analysers in patients receiving anti-thrombin therapy during cardiac catheterisation","volume":"101","author":"Chia","year":"2009","journal-title":"Thromb Haemost"},{"key":"10.1053\/j.jvca.2026.05.018_bib0010","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1186\/s13063-021-05552-7","article-title":"ACTION-1: Study protocol for a randomised controlled trial on ACT-guided heparinization during open abdominal aortic aneurysm repair","volume":"22","author":"Wiersema","year":"2021","journal-title":"Trials"},{"key":"10.1053\/j.jvca.2026.05.018_bib0011","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1177\/15266028241278137","article-title":"Clinical outcomes of 5000 IU heparin versus activated clotting time-guided heparinization during noncardiac arterial procedures: A propensity score matched analysis","volume":"33","author":"Hoebink","year":"2026","journal-title":"J Endovasc Ther"},{"key":"10.1053\/j.jvca.2026.05.018_bib0012","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/s40814-024-01500-9","article-title":"Activated clotting time-guided heparinization during open AAA surgery: A pilot study","volume":"10","author":"Roosendaal","year":"2024","journal-title":"Pilot Feasibility Stud"},{"key":"10.1053\/j.jvca.2026.05.018_bib0013","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1002\/jcla.21823","article-title":"Influence of body mass index on the activated clotting time under weight-based heparin dose","volume":"30","author":"Hong","year":"2016","journal-title":"J Clin Lab Anal"},{"key":"10.1053\/j.jvca.2026.05.018_bib0014","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1097\/EJA.0000000000000431","article-title":"Identifying optimal heparin management during cardiopulmonary bypass in obese patients: A prospective observational comparative study","volume":"33","author":"Haas","year":"2016","journal-title":"Eur J Anaesthesiol"}],"container-title":["Journal of Cardiothoracic and Vascular Anesthesia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053077026003939?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053077026003939?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T10:05:42Z","timestamp":1784541942000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1053077026003939"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":14,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S1053077026003939"],"URL":"https:\/\/doi.org\/10.1053\/j.jvca.2026.05.018","relation":{},"ISSN":["1053-0770"],"issn-type":[{"value":"1053-0770","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of Activated Clotting Time Response to Unfractionated Heparin in Vascular Surgery: An Observational Study","name":"articletitle","label":"Article Title"},{"value":"Journal of Cardiothoracic and Vascular Anesthesia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.jvca.2026.05.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}